| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |